Stripe#4

Patrick Collison@patrickc

New from Stripe Economics: The Age of the Solopreneur https://t.co/GTS8jEcK5z https://t.co/UEglqu1daG

Patrick Collison@patrickc

We have three cool announcements today: (1) @OpenAI is launching commerce in ChatGPT. Their new Instant Checkout is powered by @stripe. (2) We're releasing the Agentic Commerce Protocol, codeveloped by Stripe and OpenAI. (3) @stripe is launching an API for agentic payments, called Shared Payment Tokens. It's clear that internet purchasing modalities are going to change a lot, and we're excited to start to lay some of the foundations. Links below!

Nan Ransohoff@nanransohoff

Today we're launching Intercept: a $500M philanthropic initiative to make respiratory infections, like the common cold and flu, a thing of the past. We treat respiratory infections as a minor nuisance, but that’s really not the case. Most of us will spend 5% of our lives (!) sick from these viruses, they kill 1M people a year, cost $600B annually in productivity, and periodically threaten civilization through pandemics. So, if they’re such a big problem, why haven’t we dealt with them yet? Last year we convened ~40 leading scientists, pharma R&D leaders, biotech investors, and regulatory experts to better understand that. We heard two main reasons: (1) First, it’s just technically very challenging: respiratory viruses represent hundreds of distinct, mutating strains across several families. Fortunately, recent breakthroughs make this newly possible. (2) Second is a lack of funding: broad-spectrum solutions have historically been underfunded, in part because they’re not a great fit for most philanthropic or commercial funding (and while COVID generated a burst of activity around preventing and understanding respiratory infections through an influx of new funding, that hasn't been sustained). We think that with enough focus and funding, this might be solvable. Intercept is a $500 million philanthropic initiative that will take advantage of new tools to catalyze the development and deployment of two types of products: broad-spectrum preventatives and air cleaning technologies. This problem is undoubtedly difficult. But it’s more tractable now than it’s ever been. We think we should give it our best shot. We’re enormously grateful to our anchor funders: @stripe, @AnthropicAI, @TheFluLab, @FoundationOAI and individuals from Jane Street. And, I’m very excited to be building this with @incredutility and the rest of the team.

Andrew Curran@AndrewCurran_

OpenAI, Anthropic, Stripe and Bill Gates are putting $500 million in funding into a new organization called Intercept. Intercept's goal is to prevent the common cold and the flu, and eventually eliminate all respiratory viruses completely. https://t.co/L1434vHt8E

Cuy Sheffield@cuysheffield

1/ Today, we announced Visa is joining Open Standard alongside Stripe, Coinbase, Mastercard, American Express, Blackrock, US Bank, BBVA, Standard Chartered and 100+ initial partners with the mission of issuing Open USD, a shared stablecoin designed for the global financial system.

Charlie Petty@incredutility

I joined @Stripe in January to build a new philanthropic initiative with @nanransohoff. Today we’re announcing Intercept, a $500m innovation fund focused on radically reducing the burden of respiratory viruses. I’ve spent the past decade investing in vaccines and drugs for infectious disease, and this is the most exciting thing I’ve ever been a part of. Thrilled to be working with @Stripe, @AnthropicAI, @TheFluLab, @FoundationOAI, @coeff_giving and individuals from Jane Street. We've raised the capital and now it’s time to get to work.